Future studies should investigate whether IPMK deletion directly impacts Elk-1 activity in skeletal muscle and how this contributes to the metabolic phenotypes observed, including insulin resistance and altered lipid metabolism. The gene discussed is IPMK; the disease is Insulin resistance.